ELIZABETH GUZY: Open Payments
NPI 1528690682 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 26 payments from 6 companies in 2025. Trend: 2023 $574 · 2024 $608 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $266 |
| AERIN MEDICAL INC. | 5 | $234 |
| Optinose US, Inc. | 6 | $145 |
| Regeneron Healthcare Solutions, Inc. | 3 | $90 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Integra LifeSciences Corporation | 1 | $16 |
Products named: DUPIXENT, VIVAER STYLUS, Xhance, Ryaltris, Integra.
Industry payments across TX — which companies pay providers there.
